180 related articles for article (PubMed ID: 30855445)
1. Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer.
Qian H; Yuan D; Bao J; Liu F; Zhang W; Yang X; Han G; Huang J; Sheng H; Yu H
Medicine (Baltimore); 2019 Mar; 98(10):e14608. PubMed ID: 30855445
[TBL] [Abstract][Full Text] [Related]
2. Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers.
Demirag GG; Sullu Y; Gurgenyatagi D; Okumus NO; Yucel I
Diagn Pathol; 2011 Jan; 6():1. PubMed ID: 21194493
[TBL] [Abstract][Full Text] [Related]
3. PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer.
Lim V; Zhu H; Diao S; Hu L; Hu J
Biochem Biophys Res Commun; 2019 Jan; 508(2):646-653. PubMed ID: 30527804
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Multiple Human Tumor Cases Reveals the Carcinogenic Effects of PKP3.
Ruan S; Shi J; Wang M; Zhu Z
J Healthc Eng; 2021; 2021():9391104. PubMed ID: 34733461
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.
Sharbatoghli M; Shamshiripour P; Fattahi F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari Z; Madjd Z; Saeednejad Zanjani L
J Ovarian Res; 2022 Jan; 15(1):17. PubMed ID: 35090523
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
7. Role and function of plakophilin 3 in cancer progression and skin disease.
Zhang Y; Chen J; Tian J; Zhou Y; Liu Y
Cancer Sci; 2024 Jan; 115(1):17-23. PubMed ID: 38048779
[TBL] [Abstract][Full Text] [Related]
8. DEF6 expression in ovarian carcinoma correlates with poor patient survival.
Liew PL; Fang CY; Lee YC; Lee YC; Chen CL; Chu JS
Diagn Pathol; 2016 Aug; 11(1):68. PubMed ID: 27488395
[TBL] [Abstract][Full Text] [Related]
9. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients.
Valladares-Ayerbes M; Díaz-Prado S; Reboredo M; Medina V; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Pértega S; Santamarina I; Blanco M; Quindós-Varela M; Figueroa A; Antón-Aparicio LM
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1432-40. PubMed ID: 20501752
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.
Yu L; Zhu B; Wu S; Zhou L; Song W; Gong X; Wang D
Diagn Pathol; 2017 Mar; 12(1):23. PubMed ID: 28253891
[TBL] [Abstract][Full Text] [Related]
12. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
Zhao N; Guo Y; He Y; Chen Y; Xing J
J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
15. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
[TBL] [Abstract][Full Text] [Related]
16. Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion.
Davidson B; Smith Y; Nesland JM; Kærn J; Reich R; Tropè CG
Hum Pathol; 2013 Nov; 44(11):2449-60. PubMed ID: 24011953
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of β-catenin expression in patients with ovarian cancer: A meta-analysis.
Long H; Li G; Wen X; Lv Y; Zhang M; Wei Y; Xie W; Zhong P; Pang L
Gene; 2018 Dec; 678():270-279. PubMed ID: 30103006
[TBL] [Abstract][Full Text] [Related]
18. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases.
Fu Y; Wang X; Pan Z; Xie X
Front Med; 2014 Mar; 8(1):91-5. PubMed ID: 24370920
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
